Skip to main content
SBFM
NASDAQ Life Sciences

Sunshine Biopharma Advances Lead COVID Antiviral to IND-Enabling Studies

Tom Rudovsky · Reported by Benzinga
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.02
Mkt Cap
$3.956M
52W Low
$1.01
52W High
$24.3
52W Position info
1.0% above low
Off High info
96% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SBFM is trading near its 52-week low of $1.01 (1.0% above the low) on light trading volume (0.1× avg).

Summary

Sunshine Biopharma has moved its lead coronavirus drug candidate into IND-enabling studies, a key step toward a potential clinical trial. The company reports nanomolar potency against the viral protease, broad-spectrum activity against SARS-CoV-2 variants, strong oral bioavailability in multiple species, preferential lung enrichment, and dose-dependent viral suppression in a mouse model. This is the first disclosure of these specific preclinical results and the advancement decision. The stock trades near its 52-week low of $1.01, reflecting ongoing dilution concerns from the ATM program and warrant overhang. While the data are promising, the company has a market cap of only ~$4 million and faces significant financing challenges. The next milestone would be submission of an IND application, though no timeline was provided.

At the time of this announcement, SBFM was trading at $1.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4M. The 52-week trading range was $1.01 to $24.30. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

SBFM - Latest Insights

SBFM
Nov 18, 2026, 4:05 PM EST
Filing Type: S-1
Importance Score:
7
Price at Filing: $2.41
Real-time Price: $2.23 info
Change: -$0.1751 (-7%) info
Market Cap: $1.837M info
SBFM
Nov 12, 2026, 11:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.23 info
Change: -$0.4651 (-17%) info
Market Cap: $1.837M info
SBFM
Nov 12, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $2.23 info
Change: -$0.5751 (-20%) info
Market Cap: $1.837M info
SBFM
Nov 12, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $2.23 info
Change: -$0.5651 (-20%) info
Market Cap: $1.837M info
SBFM
Oct 22, 2026, 9:25 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1638
Real-time Price: $2.23 info
Change: Reverse Stock Split info
Market Cap: $1.837M info